CAH gains from a solid pharmaceutical segment and a diversified product portfolio. However, regulatory setbacks are a concern.
Vous n'êtes pas connecté
Cardinal Health (CAH) gains from a solid pharmaceutical segment and a diversified product portfolio. However, regulatory setbacks are a concern.
CAH gains from a solid pharmaceutical segment and a diversified product portfolio. However, regulatory setbacks are a concern.
EQR's strategy of targeting affluent renters and portfolio diversification are upsides. However, an elevated supply of rental units is a concern.
EQR's strategy of targeting affluent renters and portfolio diversification are upsides. However, an elevated supply of rental units is a concern.
RVTY's strong product portfolio raises optimism about the stock.
QDEL's strong product portfolio raises optimism about the stock.
REG is set to gain from its ownership of premium shopping centers and a solid balance sheet. However, rising e-commerce adoption and high interest...
DHR benefits from solid momentum across its Diagnostics segment. However, increasing expenses remain a concern.
PacBio's (PACB) strong product demand and continued focus on R&D raise optimism about the stock.
WELL's seniors housing operating portfolio is set to benefit from the aging population and rising healthcare spending. However, high competition is a...
WELL's seniors housing operating portfolio is set to benefit from the aging population and rising healthcare spending. However, high competition is a...